Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

Balcinrenone Plus Dapagliflozin Lowers BP, With Adriana Marton, MD

Balcinrenone Plus Dapagliflozin Lowers BP, With Adriana Marton, MD

VA Dialysis Tied to Lower Mortality, With Virginia Wang, PhD, MSPH

VA Dialysis Tied to Lower Mortality, With Virginia Wang, PhD, MSPH

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

Why Patients Miss Dialysis Treatments, With Steven Brunelli, MD Steven Brunelli, MD

A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Todays Updates

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Deep TMS Reduces Suicidal Ideation by 70% in MDD, With Owen Muir, MD Owen Muir, MD, DFAACAP, FCTMSS

A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.

Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy Marco Meglio

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

This Week on NeurologyLive® — November 2, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show Marco Meglio, Jeffrey Cohen, MD

Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Todays Updates

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Deep TMS Reduces Suicidal Ideation by 70% in MDD, With Owen Muir, MD Owen Muir, MD, DFAACAP, FCTMSS

A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.

Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy Marco Meglio

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

This Week on NeurologyLive® — November 2, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show Marco Meglio, Jeffrey Cohen, MD

Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Latest News

Balcinrenone Plus Dapagliflozin Lowers BP, With Adriana Marton, MD

VA Dialysis Tied to Lower Mortality, With Virginia Wang, PhD, MSPH

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

News All Time

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Why PAD Goes Undetected in Advanced CKD, With Pranav Garimella, MBBS, MPH Pranav Garimella, MBBS, MPH

Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D Phoom Narongkiatikhun, MD

Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.

Ochsner Health Expands Liver Transplant Access Through Multidisciplinary Care Ari Cohen, MD, MBA

Ochsner Health uses multidisciplinary clinics, living donor programs, and transplant innovations to address access challenges.

Atacicept Slows IgAN Decline to Physiologic Rate, With Sayna Norouzi, MD Sayna Norouzi, MD

Final ORIGIN 3 analysis shows a 76% lower risk of kidney disease progression vs placebo through 2 years.

How Glomerular Disease Shapes Young Women's Life Choices, With Sayna Norouzi, MD Sayna Norouzi, MD

An AHA statement co-author says reproductive and family planning concerns belong in kidney care for women with glomerular disease.

Felzartamab and the Hidden Injury of Isolated MVI, With Yasir Qazi, MD Yasir Qazi, MD

TRANSPIRE investigator Yasir Qazi, MD, explains how isolated MVI can signal kidney transplant injury before creatinine rises.

Pregnancy After Living Kidney Donation, With Amit X. Garg, MD, PhD Amit X. Garg, MD, PhD

Amit X. Garg, MD, PhD, discusses new JAMA data on preeclampsia risk after living kidney donation in a 3-part video interview.

I CAN: Ravulizumab Cuts Proteinuria 43% vs Placebo in IgA Nephropathy

I CAN: Ravulizumab Cuts Proteinuria 43% vs Placebo in IgA Nephropathy

Lorundrostat Lowers BP, Albuminuria in CKD With Uncontrolled Hypertension

Lorundrostat Lowers BP, Albuminuria in CKD With Uncontrolled Hypertension

TELIGAN: Telitacicept Preserves eGFR Through 2 Years in IgA Nephropathy Abigail Brooks, MA

Final TELIGAN data show telitacicept cut confirmed 30% eGFR decline by 89% and reduced proteinuria by 60.7% vs placebo over 2 years in IgA nephropathy.

IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy

IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy

Recommended News For You

Dense breasts: What it means and what women can do about screening

Many Americans unaware of links between HPV and cancers, poll reveals

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

New research uncovers link between cancer pathway and blood-retina barrier function

Low PSA May Not Fully Predict Survival in Prostate Cancer

Scientists call into question safety of potential new anticancer treatment

Recommended Articles For You

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Clonal Hematopoiesis and Aging: Mechanisms, Clinical Impact, and Emerging Therapies 

Screening for Early Red-Cell Deformability Changes: Clinical Relevance, Mechanisms, and Emerging Diagnostics 

Automated Platelet-Sparing Surgical Suction Systems: Mechanisms, Evidence, and Clinical Implications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV

2.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

3.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

4.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

5.

Q&A: When will individuals be able to receive customized cancer vaccines?

1.

Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life

2.

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era

3.

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough

4.

Tumor Clonal Evolution Through Single-Cell Genomics

5.

Women's Health Through Survivorship Research Focused on Female-Specific Cancer Outcomes

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

2.

Recognizing General Warning Signs of Cancer

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Hands-on Workshop: Hematology

5.

Navigating the Complexities of Ph Negative ALL - Part XIV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot